# US 2010/0137431 A1 · Use of substances that act as cascade inhibitors of the raf/mek/erk signal cascade, for producing a medicament to treat dna and rna viruses

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0137431 A1
- Document ID: US20100137431A1
- Status: Published application
- Kind: A1
- Application number: 12/470,441
- Filed: 2009-05-21
- Published: 2010-06-03
- Earliest claimed: 2000-04-07
- Inventors: Stephan Ludwig; Stephan Pleschka
- Web page: https://patentgrep.com/patent/US20100137431A1

## CPC

- A61K 31/353: 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K 31/145: having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2) (isothiourea A61K31/155)
- A61K 31/166: having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
- A61P 31/12: Antivirals
- A61P 31/14: for RNA viruses
- A61P 31/16: for influenza or rhinoviruses
- A61P 31/20: for DNA viruses
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention consists in that substances acting as cascade inhibitors of the Raf/MEK/ERK signaling pathway, in particular MEK inhibitors, are used for the production of a drug for the preventive and antiviral therapy against DNA and RNA viruses, in particular against intranuclear-replicating negative strand RNA viruses, for instance influenza or Borna disease viruses.

## Claims

### Claim 1

A method of using a MEK inhibitor to treat infections caused by negative strand RNA viruses comprising administering in a mammal a drug comprising the MEK inhibitor 1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene.

### Claim 2 (depends on 1)

The method of claim 1, wherein the MEK inhibitor is used to treat infections caused by negative strand RNA viruses which are intranuclear-replicating viruses.

### Claim 3 (depends on 1)

The method of claim 1, wherein the MEK inhibitor is used to treat infections caused by negative strand RNA viruses which are influenza or Borna viruses.
